Strategic Advisor

Phenylketonuria Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight

Systems and methods for treating depression using a digital therapeutic

Use of (1R,5S)-(+)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane in the …

Otsuka America, Inc’s. Data and Technology Company will Support Rejoyn™ Commercialization & Personalized Patient Engagement

Executive Director, Sales and Marketing, Neurology Rare Disease

Otsuka is committed to pioneering advancements in rare conditions with high unmet needs. The Executive Director, Sales and Marketing, Neurology Rare Disease will lead the brand strategy and commercial tactical planning for the upcoming Rare Disease, Neurology launch, focusing on HCP and patient engagement, and ensuring effective execution of business strategies to meet sales and operational goals.

Sign up with Google

Sign in with Google